Psychiatric Executive Formulary Committee

The HHSC Psychiatric Executive Formulary Committee maintains and updates the Psychiatric Drug Formulary by:

• Recommending standards of drug use that discourage unnecessary duplication of therapeutic alternatives and encourage the highest standards of medical and pharmacy practice.
• Reviewing periodically the drugs listed in the formulary to ensure consistency with need, effectiveness, risk and cost.
• Consulting with experts in clinical pharmacy, pharmacology and other medical specialties as needed to objectively assess drugs under consideration. 
• Adding new drugs to the formulary.
• Making other recommendations about drug use and policy as requested.
• Designating the formulations allowed for general use by service system components and their contractors.

Members

• Committee chair: David Moron, M.D., Rio Grande State Center
• Secretary: Kasey L. Pena, Pharm.D., State Hospitals
• Yekini Adeyemi, R.N., Austin State Supported Living Center
• Angela Babin, R.Ph., The Harris Center for Mental Health and IDD
• John Bennett, M.D., Dallas Metrocare Services
• Giovanna Betancourt, Pharm.D., El Paso State Supported Living Center
• Rakesh Chadalavada, M.D., Terrell State Hospital
• German Corso, M.D., Tropical Texas Behavioral Health
• Brad Fitzwater, M.D., HHSC Substance Use
• Catherine S. Hall, Pharm.D., San Antonio State Hospital
• Dana Hopkins, R.N, Austin State Hospital
• Jeffery Matthews, M.D., State Hospitals
• Leah Nunez, Pharm.D., Rio Grande State Center
• Brittany Parmentier, Pharm.D., The Harris Center for Mental Health and IDD
• Kenda Pittman, Pharm.D., State Supported Living Centers
• Sangeetha Rajan, M.D., Austin State Supported Living Center
• Rishi Sawhney, M.D., BHS Community Behavioral Health
• Lesia Trickett, M.D., State Supported Living Centers
• Ashton Wickramasinghe, M.D., State Supported Living Centers
• Patrick Young, M.D., Betty Hardwick Center

For More Information

Contact the HHSC Psychiatric Formulary Committee.